Table 3.
Associations with male partners’ pursuit of carrier screening and condition for which female partner is a carrier
| Associations with male partner testing decisions and condition | |||
|---|---|---|---|
| Disease severity categorization: moderate vs. severe/profound | |||
| Moderate | Severe/profound | Total | |
| Male partner tested | 21 | 114 | 135 |
| Male partner did not test | 21 | 25 | 46 |
| Total | 42 | 139 | p = 0.0000297*** |
| Biotinidase deficiency vs. other severe/profound conditions | |||
| Other severe/profound | Biotinidase deficiency | Total | |
| Male partner tested | 110 | 4 | 114 |
| Male partner did not test | 16 | 9 | 25 |
| Total | 126 | 13 | p = 0.000000435*** |
***p ≤ 0.001